StackTerminal.Health

BETA

KLOW Stack

B84· Mostly solid
Public 22 Jun 2026

The KLOW stack is a 4-peptide protocol targeting systemic inflammation, tissue repair, and cellular regeneration. It combines BPC-157 (gut and musculoskeletal healing), TB-500 (vascularisation and muscle/tendon recovery), KPV (anti-inflammatory gut protection), and GHK-Cu (collagen remodelling and skin/hair health). It is designed as an evolution of the GLOW stack with a stronger anti-inflammatory focus and broader systemic repair coverage.

BPC-157
Once daily — subcutaneous injection, away from meals
LOW
500mg
Thymosin Beta-4 (TB-500)
2× weekly subcutaneous injection during loading phase (4–6 weeks), then 500–1000 mcg weekly for maintenance
VERY_LOW
2000mg
KPV
Once daily — subcutaneous injection or oral on empty stomach
LOW
500mg
GHK-Cu
Once daily — subcutaneous injection or topical application
LOW
1000mg
No interactions detected
Each dose includes evidence rationale · doses personalized to your weight
AI risk assessment
Context: No wearable data
PROAI risk assessment is available with Pro.
See plans
Supplements
4 items
Once daily — subcutaneous injection, away from meals · Lyophilized powder (reconstituted)
Safety / pharmacokineticsMusculoskeletal healing (preclinical)Soft tissue healing signals (preclinical)

Promotes repair of gut lining, tendons, muscles, and connective tissue via growth hormone receptor upregulation and angiogenesis; cornerstone of the KLOW stack.

500mg
2× weekly subcutaneous injection during loading phase (4–6 weeks), then 500–1000 mcg weekly for maintenance · Lyophilized powder (reconstituted)
Wound healingWound healing (reviewed clinical context)Wound healing (clinical development)

Thymosin Beta-4 fragment that upregulates actin polymerisation, accelerates vascularisation of healing tissue, and reduces systemic inflammation; pairs synergistically with BPC-157.

2000mg
Once daily — subcutaneous injection or oral on empty stomach · Lyophilized powder (reconstituted) or oral capsule
Targeted KPV delivery for ulcerative colitis (preclinical)Colitis-associated cancer prevention (preclinical)Colitis severity reduction

Alpha-MSH-derived tripeptide with potent anti-inflammatory action in the gut; directly counteracts NF-κB signalling, reduces digestive distress, and complements BPC-157 gut-repair activity.

500mg
Once daily — subcutaneous injection or topical application · Lyophilized powder (reconstituted) or topical serum
Skin appearance / remodeling (summary of clinical + mechanistic evidence)Extracellular matrix remodeling via MMP-2 upregulationWrinkle improvement (objective measures)

Copper tripeptide that activates collagen synthesis, MMP-mediated tissue remodelling, and antioxidant gene expression; provides the skin/hair regeneration and extracellular matrix repair angle of KLOW.

1000mg
Similar community stacks
Browse all →
sleeprecoverycalm

Combining Valerian with Magnesium L-Threonate can enhance sleep quality and promote recovery. Valerian is known for its calming effects, while Magnesium L-Threonate supports relaxation and cognitive recovery.

Valerian
500mg
Magnesium L-Threonate
1500mg
New
View
recoveryskinresearch-only

Adds a copper peptide often discussed in cosmetic/skin contexts to a recovery/joint pairing. Evidence is indirect & component-based.

BPC-157
1mg
TB500 (TB4 / Thymosin Beta-4)
1mg
GHK-Cu
1mg
New
View
performanceendurancerecovery

Combining Betaine Anhydrous with Cordyceps can enhance athletic performance and endurance. Betaine supports strength and power output, while Cordyceps improves oxygen utilization and endurance.

Betaine Anhydrous
2500mg
Cordyceps (Ophiocordyceps sinensis / militaris)
1000mg
New
View
Community Insights
My notes
Sign in to keep a private note on KLOW Stack.